422 related articles for article (PubMed ID: 31054871)
1. cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells.
Shaikh MH; Bortnik V; McMillan NA; Idris A
Microb Pathog; 2019 Jul; 132():162-165. PubMed ID: 31054871
[TBL] [Abstract][Full Text] [Related]
2. Loss of HPV type 16 E7 restores cGAS-STING responses in human papilloma virus-positive oropharyngeal squamous cell carcinomas cells.
Bortnik V; Wu M; Julcher B; Salinas A; Nikolic I; Simpson KJ; McMillan NA; Idris A
J Microbiol Immunol Infect; 2021 Aug; 54(4):733-739. PubMed ID: 32768338
[TBL] [Abstract][Full Text] [Related]
3. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
4. Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers.
Saulters EL; Kennedy PT; Carter RJ; Alsufyani A; Jones TM; Woolley JF; Dahal LN
Cancer Res Commun; 2024 Jan; 4(1):118-133. PubMed ID: 38147007
[TBL] [Abstract][Full Text] [Related]
5. HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING.
Luo X; Donnelly CR; Gong W; Heath BR; Hao Y; Donnelly LA; Moghbeli T; Tan YS; Lin X; Bellile E; Kansy BA; Carey TE; Brenner JC; Cheng L; Polverini PJ; Morgan MA; Wen H; Prince ME; Ferris RL; Xie Y; Young S; Wolf GT; Chen Q; Lei YL
J Clin Invest; 2020 Apr; 130(4):1635-1652. PubMed ID: 31874109
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Bristol ML; James CD; Wang X; Fontan CT; Morgan IM
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188745
[TBL] [Abstract][Full Text] [Related]
7. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
[TBL] [Abstract][Full Text] [Related]
8. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
[TBL] [Abstract][Full Text] [Related]
9. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
Gubanova E; Brown B; Ivanov SV; Helleday T; Mills GB; Yarbrough WG; Issaeva N
Clin Cancer Res; 2012 Mar; 18(5):1257-67. PubMed ID: 22247495
[TBL] [Abstract][Full Text] [Related]
11. Automated Extraction of Formalin-Fixed, Paraffin-Embedded Tissue for High-Risk Human Papillomavirus Testing of Head and Neck Squamous Cell Carcinomas Using the Roche Cobas 4800 System.
Kerr DA; Sweeney B; Arpin RN; Ring M; Pitman MB; Wilbur DC; Faquin WC
Arch Pathol Lab Med; 2016 Aug; 140(8):844-8. PubMed ID: 27031775
[TBL] [Abstract][Full Text] [Related]
12. DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas.
Holcomb AJ; Brown L; Tawfik O; Madan R; Shnayder Y; Thomas SM; Wallace NA
Virology; 2020 Sep; 548():174-181. PubMed ID: 32838940
[TBL] [Abstract][Full Text] [Related]
13. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
14. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
16. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
17. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
[TBL] [Abstract][Full Text] [Related]
19. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
[TBL] [Abstract][Full Text] [Related]
20. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
